Cite
Bandak M, Jensen A, Dehlendorff C, et al. Paternity After Treatment for Testicular Germ Cell Cancer: A Danish Nationwide Population-Based Cohort Study. J Natl Cancer Inst. 2022;114(1):149-155doi: 10.1093/jnci/djab130.
Bandak, M., Jensen, A., Dehlendorff, C., Lauritsen, J., Kreiberg, M., Wagner, T., Rosenvilde, J., & Daugaard, G. (2022). Paternity After Treatment for Testicular Germ Cell Cancer: A Danish Nationwide Population-Based Cohort Study. Journal of the National Cancer Institute, 114(1), 149-155. https://doi.org/10.1093/jnci/djab130
Bandak, Mikkel, et al. "Paternity After Treatment for Testicular Germ Cell Cancer: A Danish Nationwide Population-Based Cohort Study." Journal of the National Cancer Institute vol. 114,1 (2022): 149-155. doi: https://doi.org/10.1093/jnci/djab130
Bandak M, Jensen A, Dehlendorff C, Lauritsen J, Kreiberg M, Wagner T, Rosenvilde J, Daugaard G. Paternity After Treatment for Testicular Germ Cell Cancer: A Danish Nationwide Population-Based Cohort Study. J Natl Cancer Inst. 2022 Jan 11;114(1):149-155. doi: 10.1093/jnci/djab130. PMID: 34180995.
Copy
Download .nbib